Nanobacteria
[back] Vaccine contamination

[2001] Another debate in viral vaccines: nanobacterial contamination

Fetal Bovine Serum & Nanobacteria

Breitschwerdt EB, Sontakke S, Cannedy A, Hancock SI, Bradley JM. Infection with Bartonella weissii and detection of Nanobacterium antigens in a North Carolina beef herd. J Clin Microbiol 2001 Mar;39(3):879-82. PMID 11230398. Full article text available at http://jcm.asm.org/cgi/content/full/39/3/879?view=full&pmid=11230398

Nanobacteria detected in vaccines. NanoNews 2001 July;1(2). Article available at http://www.nanobaclabs.com/Files/Newsletter/JulyNANONEWS1.pdf

Nanobacteria In Vaccines  Made Of BSE-Possible Bovine Material From Patricia Doyle, PhD

[2005] The Nanobacteria Link to Heart Disease and Cancer by Douglas Mulhall

[1997] A New Potential Threat in Antigen and Antibody Products: Nanobacteria

Quotes
In May 2005, Dr Olavi Kajander delivered a sobering message to a joint meeting of the US FDA and the European Medicines Agency on viral safety when he presented new evidence to support something first published in 1997: that vaccines are contaminated with nanobacteria.  Since 1999, government agencies have done virtually nothing to investigate the claim, due largely to that NIH experiment which failed to use particles discovered by Kajander as control samples; so now that the vaccine contamination has been officially reported to authorities, the question is: what will be done? [2005] The Nanobacteria Link to Heart Disease and Cancer by Douglas Mulhall

Nanobacteria are novel microorganisms that are not detectable with present sterility testing methods, but they are detectable with new culture and immunomethods. They are commonly present in bovine and blood products and thus in cell cultures and antigens, including vaccines derived therefrom, and may be present in antibody and gammaglobulin products. Nanobacteria are a potential risk because of their cytotoxic properties and ability to infect fetuses, and thus their pathogenicity should be scrutinized. [1997] A New Potential Threat in Antigen and Antibody Products: Nanobacteria